AACR 2022 | The future of diagnostic imaging in oncology using AI

Ángel Alberich-Bayarri, PhD, QUIBIM – Quantitative Imaging Biomarkers in Medicine, Valencia, Spain, discusses the uses of artificial intelligence (AI) in radiology. There is great potential for the development of robust, noninvasive diagnostics with AI and radiomics. Immortal biopsy samples could be used to stratify disease subtypes, identify at-risk patients, monitor treatment response, and anticipate adverse events. Diagnostic imaging in oncology is currently not approved by the FDA. This interview took place at the American Association for Cancer Research Annual Meeting in New Orleans, LA.